Gillian F. Ellsbury
Tadworth, ENG, United Kingdom
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 24 publications
Could more adults than just those aged 75-79 years potentially benefit from vaccination against RSV: insights from UK data.
Journal: Journal of pharmaceutical policy and practice
Published: November 07, 2025
How do Recent Population-Level RSVpreF Vaccine-Impact Results from the United Kingdom Relate to Previously Reported Vaccine Effectiveness Results?
Journal: Infectious diseases and therapy
Published: October 29, 2025
Adult risk groups for vaccine preventable respiratory infections: an overview of the UK environment.
Adult risk groups for vaccine preventable respiratory infections: an overview of the UK environment.
Journal: Expert review of vaccines
Published: November 14, 2024
Emergency department presentations of community-acquired lower respiratory tract disease in Bristol, UK: a prospective cohort study 2022-2023.
Journal: BMJ open respiratory research
Published: May 14, 2024
A review of evidence for pneumococcal vaccination in adults at increased risk of pneumococcal disease: risk group definitions and optimization of vaccination coverage in the United Kingdom.
Journal: Expert review of vaccines
Published: September 11, 2023
Impact of SARS-CoV-2 infective exacerbation of chronic obstructive pulmonary disease on clinical outcomes in a prospective cohort study of hospitalised adults.
Journal: Journal of the Royal Society of Medicine
Published: July 05, 2023
Cost-effectiveness of using a 20-valent pneumococcal conjugate vaccine to directly protect adults in England at elevated risk of pneumococcal disease.
Journal: Expert review of pharmacoeconomics & outcomes research
Published: October 13, 2022
Incidence of community acquired lower respiratory tract disease in Bristol, UK during the COVID-19 pandemic: A prospective cohort study.
Journal: The Lancet regional health. Europe
Published: August 15, 2022
Public health and budgetary impact of 20-valent pneumococcal conjugate vaccine for adults in England.
Journal: Expert review of vaccines
Published: August 05, 2022
Severity of Omicron (B.1.1.529) and Delta (B.1.617.2) SARS-CoV-2 infection among hospitalised adults: A prospective cohort study in Bristol, United Kingdom.
Journal: The Lancet regional health. Europe
Published: July 29, 2022
A novel approach to estimate the local population denominator to calculate disease incidence for hospital-based health events in England.
Journal: Epidemiology and infection
Published: July 11, 2022
Last Updated: 09/26/2026